Suberville, M.; Zhang, K.; Woillard, J.B.; Herafa, I.; Ducoux, D.; Nachef, R.; Teoh, J.; Zhu, G.; Ng, C.-F.; Laguna, P.;
et al. Oncological and Functional Outcomes of Hemi-Ablation Versus Focal Ablation for Localized Prostate Cancer Using Irreversible Electroporation. Cancers 2025, 17, 2084.
https://doi.org/10.3390/cancers17132084
AMA Style
Suberville M, Zhang K, Woillard JB, Herafa I, Ducoux D, Nachef R, Teoh J, Zhu G, Ng C-F, Laguna P,
et al. Oncological and Functional Outcomes of Hemi-Ablation Versus Focal Ablation for Localized Prostate Cancer Using Irreversible Electroporation. Cancers. 2025; 17(13):2084.
https://doi.org/10.3390/cancers17132084
Chicago/Turabian Style
Suberville, Michel, Kai Zhang, Jean Baptiste Woillard, Isabelle Herafa, Dorothée Ducoux, Rachid Nachef, Jeremy Teoh, Gang Zhu, Chi-Fai Ng, Pilar Laguna,
and et al. 2025. "Oncological and Functional Outcomes of Hemi-Ablation Versus Focal Ablation for Localized Prostate Cancer Using Irreversible Electroporation" Cancers 17, no. 13: 2084.
https://doi.org/10.3390/cancers17132084
APA Style
Suberville, M., Zhang, K., Woillard, J. B., Herafa, I., Ducoux, D., Nachef, R., Teoh, J., Zhu, G., Ng, C.-F., Laguna, P., & de la Rosette, J.
(2025). Oncological and Functional Outcomes of Hemi-Ablation Versus Focal Ablation for Localized Prostate Cancer Using Irreversible Electroporation. Cancers, 17(13), 2084.
https://doi.org/10.3390/cancers17132084
